HIF1α-dependent metabolic reprogramming governs mesenchymal stem/stromal cell immunoregulatory functions

Area of Science:

• Immunology
• Cell Biology
• Metabolic Regulation

Background:

• Mesenchymal stem/stromal cells (MSCs) possess immunomodulatory properties.
• Hypoxia-inducible factor 1 α (HIF1α) regulates MSC survival and differentiation.
• The role of HIF1α in MSC immunosuppression requires further investigation.

Purpose of the Study:

• To elucidate the role of HIF1α in the immunosuppressive activity of MSCs.
• To determine how HIF1α influences MSC metabolism and mediator production.
• To validate the in vivo impact of HIF1α on MSC immunotherapeutic potential.

Main Methods:

• HIF1α silencing in MSCs.
• Assessment of MSCs inhibitory effects on Th1 and Th17 cell differentiation.
• Analysis of regulatory T cell generation.
• Metabolic profiling (glycolysis vs. OXPHOS).
• Measurement of immunosuppressive mediators (ICAM, IL-6, NO).
• In vivo studies using a Delayed-Type Hypersensitivity (DTH) murine model.

Main Results:

• HIF1α silencing reduced MSCs ability to inhibit Th1/Th17 generation and regulatory T cell induction.
• Silencing led to a metabolic switch from glycolysis to OXPHOS in MSCs.
• Reduced expression/production of ICAM, IL-6, and NO was observed.
• In vivo, HIF1α-silenced MSCs showed impaired anti-inflammatory effects and reduced inhibition of pro-inflammatory T cells in the DTH model.

Conclusions:

• HIF1α plays a pivotal role in mediating MSC immunosuppressive activity.
• HIF1α regulates MSCs metabolic status, influencing their immunomodulatory functions.
• HIF1α represents a novel target for enhancing MSC-based immunotherapies.